07/01/2025
6:40 AM | AlloVir (Filer)
Kalaris Therapeutics, Inc. (Filer)
| Form ARS | |
07/01/2025
6:30 AM | AlloVir (Filer)
Kalaris Therapeutics, Inc. (Filer)
| Form DEF 14A | |
07/01/2025
6:35 AM | AlloVir (Filer)
Kalaris Therapeutics, Inc. (Filer)
| Form DEFA14A | |
06/20/2025
6:20 AM | AlloVir (Filer)
Kalaris Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/15/2025
1:06 PM | EcoR1 Capital, LLC (Filed by)
AlloVir (Subject)
Kalaris Therapeutics, Inc. (Subject)
| Form SCHEDULE 13G/A | |
05/14/2025
7:09 AM | AlloVir (Filer)
Kalaris Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/16/2025
3:18 PM | AlloVir (Filer)
Kalaris Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/11/2025
4:04 PM | AlloVir (Issuer)
Kalaris Therapeutics, Inc. (Issuer)
PATEL SAMIR CHANDRAKANT (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/11/2025
4:08 PM | Jovan-Embiricos Morana (Reporting)
AlloVir (Issuer)
Kalaris Therapeutics, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/11/2025
4:20 PM | AKKARAJU SRINIVAS (Reporting)
AlloVir (Issuer)
Kalaris Therapeutics, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/11/2025
4:27 PM | Hagen Brett R (Reporting)
AlloVir (Issuer)
Kalaris Therapeutics, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for ALVR and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for AlloVir and its competitors with MarketBeat's FREE daily newsletter. |
04/11/2025
4:03 PM | Ferrara Napoleone (Reporting)
AlloVir (Issuer)
Kalaris Therapeutics, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/11/2025
3:41 PM | Hallal David (Reporting)
AlloVir (Issuer)
Kalaris Therapeutics, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/04/2025
7:21 AM | AlloVir (Issuer)
Kalaris Therapeutics, Inc. (Issuer)
PATTERSON LEONE D (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
04/04/2025
7:12 AM | AlloVir (Filer)
Kalaris Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/27/2025
6:19 PM | Hagen Brett R (Reporting)
AlloVir (Issuer)
Kalaris Therapeutics, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/26/2025
4:06 PM | AKKARAJU SRINIVAS (Reporting)
AlloVir (Issuer)
Kalaris Therapeutics, Inc. (Issuer)
| Form 3/A | |
03/25/2025
6:38 PM | AlloVir (Issuer)
Kalaris Therapeutics, Inc. (Issuer)
Samsara BioCapital GP, LLC (Reporting)
Samsara BioCapital, L.P. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
03/25/2025
6:40 PM | AlloVir (Subject)
Kalaris Therapeutics, Inc. (Subject)
Samsara BioCapital, L.P. (Filed by)
| Form SCHEDULE 13D | |
03/20/2025
3:32 PM | GILEAD SCIENCES, INC. (Filed by)
AlloVir (Subject)
Kalaris Therapeutics, Inc. (Subject)
| Form SCHEDULE 13G/A | |
03/18/2025
4:44 PM | AlloVir (Issuer)
Kalaris Therapeutics, Inc. (Issuer)
PATEL SAMIR CHANDRAKANT (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2025
4:45 PM | Ferrara Napoleone (Reporting)
AlloVir (Issuer)
Kalaris Therapeutics, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2025
4:37 PM | ADAMIS ANTHONY P (Reporting)
AlloVir (Issuer)
Kalaris Therapeutics, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2025
4:40 PM | AKKARAJU SRINIVAS (Reporting)
AlloVir (Issuer)
Kalaris Therapeutics, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2025
4:41 PM | AlloVir (Issuer)
Kalaris Therapeutics, Inc. (Issuer)
Oxtoby Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2025
4:43 PM | Feinsod Matthew (Reporting)
AlloVir (Issuer)
Kalaris Therapeutics, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2025
4:25 PM | Dybbs Michael (Reporting)
AlloVir (Issuer)
Kalaris Therapeutics, Inc. (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
03/18/2025
4:27 PM | Ferrara Napoleone (Reporting)
AlloVir (Issuer)
Kalaris Therapeutics, Inc. (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
03/18/2025
4:30 PM | AKKARAJU SRINIVAS (Reporting)
AlloVir (Issuer)
Kalaris Therapeutics, Inc. (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
03/18/2025
4:14 PM | ADAMIS ANTHONY P (Reporting)
AlloVir (Issuer)
Kalaris Therapeutics, Inc. (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
03/18/2025
4:17 PM | Feinsod Matthew (Reporting)
AlloVir (Issuer)
Kalaris Therapeutics, Inc. (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
03/18/2025
4:20 PM | AlloVir (Issuer)
Kalaris Therapeutics, Inc. (Issuer)
Oxtoby Andrew (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
03/18/2025
4:21 PM | AlloVir (Issuer)
Kalaris Therapeutics, Inc. (Issuer)
PATEL SAMIR CHANDRAKANT (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
03/18/2025
4:04 PM | AlloVir (Filer)
Kalaris Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/12/2025
3:18 PM | AlloVir (Filer)
Allovir, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/07/2025
6:30 AM | AlloVir (Filer)
Allovir, Inc. (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/24/2025
10:51 AM | AlloVir (Subject)
Allovir, Inc. (Subject)
Hagen Brett R (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/24/2025
10:55 AM | AlloVir (Subject)
Allovir, Inc. (Subject)
Miller Edward (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/24/2025
10:56 AM | AlloVir (Subject)
Allovir, Inc. (Subject)
Sinha Vikas (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/14/2025
12:17 PM | AlloVir (Subject)
Allovir, Inc. (Subject)
EcoR1 Capital, LLC (Filed by)
| Form SCHEDULE 13G/A | |
02/10/2025
11:15 PM | AlloVir (Filer)
Allovir, Inc. (Filer)
| Form EFFECT | |
Trump wipes out trillions overnight… (Ad) Is there anybody more powerful than Donald Trump right now?
In a single tariff announcement, he wiped out nearly $5 trillion in wealth from the S&P 500 and $6.4 trillion from the Dow Jones…
Not to mention the countless trillions of dollars lost in every market around the world… leaving the major political powers scrambling in fear of Trump’s next move. Whether you take some of that wealth for yourself depends on if you watch this controversial exposé |
02/10/2025
3:19 PM | AlloVir (Filer)
Allovir, Inc. (Filer)
| Form 424B3 | |
01/24/2025
1:51 PM | AlloVir (Subject)
Allovir, Inc. (Subject)
Hagen Brett R (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/24/2025
1:55 PM | AlloVir (Subject)
Allovir, Inc. (Subject)
Miller Edward (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/24/2025
2:03 PM | AlloVir (Subject)
Allovir, Inc. (Subject)
Sinha Vikas (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/15/2025
3:39 PM | AlloVir (Filer)
Allovir, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/15/2025
3:41 PM | AlloVir (Subject)
Allovir, Inc. (Subject)
| Form 425 | |
01/13/2025
3:15 PM | AlloVir (Issuer)
Allovir, Inc. (Issuer)
Sinha Vikas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/13/2025
3:15 PM | AlloVir (Issuer)
Allovir, Inc. (Issuer)
Hagen Brett R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/13/2025
3:15 PM | AlloVir (Issuer)
Allovir, Inc. (Issuer)
Miller Edward (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/10/2025
7:00 PM | AlloVir (Subject)
Allovir, Inc. (Subject)
Hagen Brett R (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/10/2025
7:00 PM | AlloVir (Subject)
Allovir, Inc. (Subject)
Sinha Vikas (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/10/2025
7:00 PM | AlloVir (Subject)
Allovir, Inc. (Subject)
Miller Edward (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/10/2025
6:44 AM | AlloVir (Subject)
Allovir, Inc. (Subject)
| Form 425 | |
01/10/2025
6:42 AM | AlloVir (Filer)
Allovir, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/20/2024
3:21 PM | AlloVir (Filer)
Allovir, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/20/2024
3:23 PM | AlloVir (Subject)
Allovir, Inc. (Subject)
| Form 425 | |
12/11/2024
4:07 PM | AlloVir (Issuer)
Allovir, Inc. (Issuer)
Miller Edward (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/09/2024
5:37 AM | AlloVir (Filer)
Allovir, Inc. (Filer)
| Form S-4
Registration statement under Securities Act of 1933 | |
12/06/2024
8:50 PM | AlloVir (Subject)
Allovir, Inc. (Subject)
| Form 425 | |
12/06/2024
6:23 AM | AlloVir (Filer)
Allovir, Inc. (Filer)
| Form DEF 14A | |
11/20/2024
3:15 PM | AlloVir (Issuer)
Allovir, Inc. (Issuer)
Brainard Diana (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/20/2024
3:15 PM | AlloVir (Issuer)
Allovir, Inc. (Issuer)
Miller Edward (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/20/2024
3:15 PM | AlloVir (Issuer)
Allovir, Inc. (Issuer)
Sinha Vikas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/20/2024
3:15 PM | AlloVir (Issuer)
Allovir, Inc. (Issuer)
Hagen Brett R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/19/2024
7:00 PM | AlloVir (Subject)
Allovir, Inc. (Subject)
Hagen Brett R (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/19/2024
7:00 PM | AlloVir (Subject)
Allovir, Inc. (Subject)
Brainard Diana (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/19/2024
7:00 PM | AlloVir (Subject)
Allovir, Inc. (Subject)
Miller Edward (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/19/2024
7:00 PM | AlloVir (Subject)
Allovir, Inc. (Subject)
Sinha Vikas (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/08/2024
3:05 PM | AlloVir (Subject)
Allovir, Inc. (Subject)
| Form 425 | |
11/08/2024
3:06 PM | AlloVir (Subject)
Allovir, Inc. (Subject)
| Form 425 | |
11/08/2024
3:09 PM | AlloVir (Subject)
Allovir, Inc. (Subject)
| Form 425 | |
11/08/2024
3:10 PM | AlloVir (Subject)
Allovir, Inc. (Subject)
| Form 425 | |
11/08/2024
7:26 AM | AlloVir (Filer)
Allovir, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/08/2024
7:33 AM | AlloVir (Subject)
Allovir, Inc. (Subject)
| Form 425 | |
11/05/2024
7:00 PM | AlloVir (Subject)
Allovir, Inc. (Subject)
Sinha Vikas (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/05/2024
7:00 PM | AlloVir (Subject)
Allovir, Inc. (Subject)
Hagen Brett R (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/05/2024
7:00 PM | AlloVir (Subject)
Allovir, Inc. (Subject)
Miller Edward (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/05/2024
7:00 PM | AlloVir (Subject)
Allovir, Inc. (Subject)
Brainard Diana (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/23/2024
3:15 PM | AlloVir (Issuer)
Allovir, Inc. (Issuer)
Miller Edward (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/23/2024
3:15 PM | AlloVir (Issuer)
Allovir, Inc. (Issuer)
Hagen Brett R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/23/2024
3:15 PM | AlloVir (Issuer)
Allovir, Inc. (Issuer)
Sinha Vikas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/23/2024
3:15 PM | AlloVir (Issuer)
Allovir, Inc. (Issuer)
Brainard Diana (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/22/2024
7:00 PM | AlloVir (Subject)
Allovir, Inc. (Subject)
Sinha Vikas (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/22/2024
7:00 PM | AlloVir (Subject)
Allovir, Inc. (Subject)
Miller Edward (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/22/2024
7:00 PM | AlloVir (Subject)
Allovir, Inc. (Subject)
Hagen Brett R (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/21/2024
7:00 PM | AlloVir (Subject)
Allovir, Inc. (Subject)
Miller Edward (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/21/2024
7:00 PM | AlloVir (Subject)
Allovir, Inc. (Subject)
Brainard Diana (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/21/2024
7:00 PM | AlloVir (Subject)
Allovir, Inc. (Subject)
Sinha Vikas (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/21/2024
7:00 PM | AlloVir (Subject)
Allovir, Inc. (Subject)
Hagen Brett R (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/04/2024
3:15 PM | AlloVir (Issuer)
Allovir, Inc. (Issuer)
Hagen Brett R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
I was wrong about Trump (Ad) I made a mistake.
A mistake I feel very foolish about.
After speaking with Donald Trump and some of his advisors, I believed him.
I believed the promise that he would finally confront the single most dangerous threat to American life. That he would fix the ticking time bomb I’ve been warning about for 15 years.
But I was wrong. Let me show you exactly what we’re doing to prepare. |
10/04/2024
3:15 PM | AlloVir (Issuer)
Allovir, Inc. (Issuer)
Brainard Diana (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/04/2024
3:15 PM | AlloVir (Issuer)
Allovir, Inc. (Issuer)
Miller Edward (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/04/2024
3:15 PM | AlloVir (Issuer)
Allovir, Inc. (Issuer)
Sinha Vikas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2024
7:00 PM | AlloVir (Subject)
Allovir, Inc. (Subject)
Miller Edward (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/03/2024
7:00 PM | AlloVir (Subject)
Allovir, Inc. (Subject)
Sinha Vikas (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/03/2024
7:00 PM | AlloVir (Subject)
Allovir, Inc. (Subject)
Hagen Brett R (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/03/2024
7:00 PM | AlloVir (Subject)
Allovir, Inc. (Subject)
Brainard Diana (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/22/2024
3:15 PM | AlloVir (Issuer)
Allovir, Inc. (Issuer)
Brainard Diana (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/21/2024
10:14 AM | AlloVir (Subject)
Allovir, Inc. (Subject)
Brainard Diana (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
